Argent BioPharma Limited
Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company's principal product candidates include CimetrA, which is in phase III clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I c… Read more
Market Cap & Net Worth: Argent BioPharma Limited (RGTLF)
Argent BioPharma Limited (PINK:RGTLF) has a market capitalization of $5.07 Million ($5.07 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #34300 globally and #11177 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Argent BioPharma Limited's stock price $0.06 by its total outstanding shares 87942317 (87.94 Million).
Argent BioPharma Limited Market Cap History: 2025 to 2025
Argent BioPharma Limited's market capitalization history from 2025 to 2025. Data shows growth from $5.07 Million to $5.07 Million (0.00% CAGR).
Argent BioPharma Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Argent BioPharma Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
8.70x
Argent BioPharma Limited's market cap is 8.70 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $5.07 Million | $583.45K | -$17.84 Million | 8.70x | N/A |
Competitor Companies of RGTLF by Market Capitalization
Companies near Argent BioPharma Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Argent BioPharma Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Argent BioPharma Limited Historical Marketcap From 2025 to 2025
Between 2025 and today, Argent BioPharma Limited's market cap moved from $5.07 Million to $ 5.07 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $5.07 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Argent BioPharma Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.07 Million USD |
| MoneyControl | $5.07 Million USD |
| MarketWatch | $5.07 Million USD |
| marketcap.company | $5.07 Million USD |
| Reuters | $5.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.